JP2006508993A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006508993A5 JP2006508993A5 JP2004554476A JP2004554476A JP2006508993A5 JP 2006508993 A5 JP2006508993 A5 JP 2006508993A5 JP 2004554476 A JP2004554476 A JP 2004554476A JP 2004554476 A JP2004554476 A JP 2004554476A JP 2006508993 A5 JP2006508993 A5 JP 2006508993A5
- Authority
- JP
- Japan
- Prior art keywords
- formoterol
- roflumilast
- pharmaceutical
- daily dose
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02026504 | 2002-11-27 | ||
| PCT/EP2003/013266 WO2004047828A1 (en) | 2002-11-27 | 2003-11-26 | Synergistic combination compresing roflumilas and (r.r) -formoterol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006508993A JP2006508993A (ja) | 2006-03-16 |
| JP2006508993A5 true JP2006508993A5 (enExample) | 2006-11-30 |
Family
ID=32338001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004554476A Pending JP2006508993A (ja) | 2002-11-27 | 2003-11-26 | ロフルミラスト及び（ｒ，ｒ）−ホルモテロールを含有する新規の相乗組合せ |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20060199865A1 (enExample) |
| EP (1) | EP1567140B1 (enExample) |
| JP (1) | JP2006508993A (enExample) |
| KR (1) | KR20050094810A (enExample) |
| CN (1) | CN1713902A (enExample) |
| AT (1) | ATE399544T1 (enExample) |
| AU (1) | AU2003288169B8 (enExample) |
| BR (1) | BR0316475A (enExample) |
| CA (1) | CA2506956C (enExample) |
| CO (1) | CO5690571A2 (enExample) |
| CY (1) | CY1110368T1 (enExample) |
| DE (1) | DE60321954D1 (enExample) |
| DK (1) | DK1567140T3 (enExample) |
| EA (1) | EA009990B1 (enExample) |
| ES (1) | ES2309374T3 (enExample) |
| HR (1) | HRP20050580B1 (enExample) |
| IL (1) | IL168307A (enExample) |
| IS (1) | IS2576B (enExample) |
| MA (1) | MA27538A1 (enExample) |
| ME (1) | ME00488B (enExample) |
| MX (1) | MXPA05005438A (enExample) |
| NO (1) | NO334148B1 (enExample) |
| NZ (1) | NZ540658A (enExample) |
| PL (1) | PL214869B1 (enExample) |
| PT (1) | PT1567140E (enExample) |
| RS (1) | RS51082B (enExample) |
| SI (1) | SI1567140T1 (enExample) |
| TN (1) | TNSN05130A1 (enExample) |
| UA (1) | UA83017C2 (enExample) |
| WO (1) | WO2004047828A1 (enExample) |
| ZA (1) | ZA200503307B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| DK1606261T3 (da) | 2003-03-10 | 2010-01-18 | Nycomed Gmbh | Hidtil ukendt fremgangsmåde til fremstilling af roflumilast |
| AU2006224619B2 (en) | 2005-03-16 | 2012-06-07 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| WO2013077830A1 (en) * | 2011-11-25 | 2013-05-30 | Mahmut Bilgic | Synergistilly active combinations of roflumilast and carmoterol |
| CN103784443A (zh) * | 2014-02-18 | 2014-05-14 | 青岛市城阳区人民医院 | 一种包含沙美特罗和罗氟司特的药物组合产品 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| EP0938467B1 (en) * | 1996-11-11 | 2002-06-12 | Sepracor, Inc. | Process for the preparation of optically pure isomers of formoterol |
| DE69835594T2 (de) * | 1997-02-17 | 2007-08-16 | Altana Pharma Ag | Zusammensetzungen zur behandlung von irds oder ards die 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten |
| DK0975347T3 (da) * | 1997-02-28 | 2008-06-16 | Nycomed Gmbh | Synergistisk kombination af PDE-inhibitorer og adenylatcyclase-agonister eller guanylcyclyseagonister |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| CZ293735B6 (cs) * | 1998-08-26 | 2004-07-14 | Smithkline Beecham Corporation | Farmaceutický prostředek pro léčbu plicní nemoci |
| US6303145B2 (en) * | 1999-05-10 | 2001-10-16 | Sepracor Inc. | (S,R) formoterol methods and compositions |
| CA2715683A1 (en) * | 1999-08-21 | 2001-03-01 | Nycomed Gmbh | Synergistic combination |
| GB0103630D0 (en) * | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| WO2002076933A1 (en) * | 2001-03-22 | 2002-10-03 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
| WO2002088167A1 (en) * | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
-
2003
- 2003-11-26 KR KR1020057009176A patent/KR20050094810A/ko not_active Ceased
- 2003-11-26 PT PT03780056T patent/PT1567140E/pt unknown
- 2003-11-26 CN CNA2003801036335A patent/CN1713902A/zh active Pending
- 2003-11-26 EP EP03780056A patent/EP1567140B1/en not_active Expired - Lifetime
- 2003-11-26 AT AT03780056T patent/ATE399544T1/de active
- 2003-11-26 DK DK03780056T patent/DK1567140T3/da active
- 2003-11-26 ME MEP-2008-781A patent/ME00488B/me unknown
- 2003-11-26 MX MXPA05005438A patent/MXPA05005438A/es active IP Right Grant
- 2003-11-26 EA EA200500865A patent/EA009990B1/ru not_active IP Right Cessation
- 2003-11-26 NZ NZ540658A patent/NZ540658A/en not_active IP Right Cessation
- 2003-11-26 BR BR0316475-6A patent/BR0316475A/pt not_active IP Right Cessation
- 2003-11-26 UA UAA200505965A patent/UA83017C2/uk unknown
- 2003-11-26 SI SI200331345T patent/SI1567140T1/sl unknown
- 2003-11-26 HR HRP20050580AA patent/HRP20050580B1/hr not_active IP Right Cessation
- 2003-11-26 WO PCT/EP2003/013266 patent/WO2004047828A1/en not_active Ceased
- 2003-11-26 DE DE60321954T patent/DE60321954D1/de not_active Expired - Lifetime
- 2003-11-26 PL PL375632A patent/PL214869B1/pl unknown
- 2003-11-26 US US10/535,817 patent/US20060199865A1/en not_active Abandoned
- 2003-11-26 RS YUP-2005/0383A patent/RS51082B/sr unknown
- 2003-11-26 AU AU2003288169A patent/AU2003288169B8/en not_active Ceased
- 2003-11-26 CA CA2506956A patent/CA2506956C/en not_active Expired - Fee Related
- 2003-11-26 ES ES03780056T patent/ES2309374T3/es not_active Expired - Lifetime
- 2003-11-26 JP JP2004554476A patent/JP2006508993A/ja active Pending
-
2005
- 2005-04-25 ZA ZA200503307A patent/ZA200503307B/en unknown
- 2005-05-01 IL IL168307A patent/IL168307A/en not_active IP Right Cessation
- 2005-05-10 TN TNP2005000130A patent/TNSN05130A1/en unknown
- 2005-06-16 MA MA28342A patent/MA27538A1/fr unknown
- 2005-06-20 IS IS7899A patent/IS2576B/is unknown
- 2005-06-20 NO NO20053023A patent/NO334148B1/no not_active IP Right Cessation
- 2005-06-27 CO CO05062790A patent/CO5690571A2/es not_active Application Discontinuation
-
2008
- 2008-09-17 CY CY20081101016T patent/CY1110368T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022180461A5 (enExample) | ||
| US6790465B2 (en) | Composition and method for treating snoring | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| RU2019100425A (ru) | Новая доза и препаративная форма | |
| JP2007520506A5 (enExample) | ||
| JP6762931B2 (ja) | 経鼻組成物と該経鼻組成物の使用方法の改善 | |
| JP2014528474A5 (enExample) | ||
| CN108040468B (zh) | 用于治疗口腔、咽喉和呼吸道疾病的制剂 | |
| TW202142232A (zh) | 用於治療、改善或預防冠狀病毒感染之製品與方法 | |
| JP2005508963A5 (enExample) | ||
| JP2016138142A (ja) | 大うつ病を有する患者において減量療法を提供する方法 | |
| JP2005508963A (ja) | 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JP2016505050A5 (enExample) | ||
| JP2006508994A5 (enExample) | ||
| JP2011500589A5 (enExample) | ||
| CN102772578B (zh) | 一种用于治疗脚气的中药组合物 | |
| JP2023523557A5 (enExample) | ||
| CA2506962A1 (en) | Synergistic combination comprising roflumilast and formoterol | |
| CN119700755B (zh) | 化合物在制备预防和/或治疗高原病的药物中的应用 | |
| JP2009534367A5 (enExample) | ||
| CA2506956A1 (en) | Synergistic combination comprising roflumilast and (r,r)-formoterol | |
| JP2017511307A5 (enExample) | ||
| JP2014528458A (ja) | 鼻炎の治療 |